(Q38051261)

27 August 2017

0 references

The autoimmune side of heart and lung diseases (English)

1 reference

27 August 2017

1

Nancy Agmon-Levin

1 reference

27 August 2017

2

Carlo Selmi

1 reference

27 August 2017

1 February 2013

1 reference

Clinical Reviews in Allergy & Immunology

27 August 2017

1 reference

27 August 2017

44

1 reference

27 August 2017

1

1 reference

27 August 2017

1-5

1 reference

https://scigraph.springernature.com/pub.10.1007/s12016-012-8335-x

27 August 2017

0 references

cites work

Chitinase 1 is a biomarker for and therapeutic target in scleroderma-associated interstitial lung disease that augments TGF-β1 signaling

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Cutting edge issues in the Churg-Strauss syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Cardiovascular risk in rheumatoid arthritis and systemic autoimmune rheumatic disorders: a suggested model of preventive strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Nasal cardiac myosin peptide treatment and OX40 blockade protect mice from acute and chronic virally-induced myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

The clinical and diagnostic significance of anti-myosin autoantibodies in cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

The clinical significance of anti-beta-1 adrenergic receptor autoantibodies in cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Th17 cells can provide B cell help in autoantibody induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Congenital heart block: identification of autoantibody binding site on the extracellular loop (domain I, S5-S6) of alpha(1D) L-type Ca channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Novel autoantibody markers for early and seronegative rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

SLE diagnosis and treatment: when early is early

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

The meaning of anti-Ro and anti-La antibodies in primary Sjögren's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Definition of human autoimmunity--autoantibodies versus autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Innate immunity in systemic lupus erythematosus: sensing endogenous nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Innate versus acquired immune response in the pathogenesis of recurrent idiopathic pericarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Innate immunity in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Predictive factors of response to rituximab therapy in rheumatoid arthritis: What do we know today?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

The dual effects of B cell depletion on antigen-specific T cells in BDC2.5NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

A CD8+ T cell transcription signature predicts prognosis in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Epigenetics and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Epigenetics lessons from twins: prospects for autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

The role of epigenetics in aging and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Epigenetics in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Epigenetic perspectives in systemic lupus erythematosus: pathogenesis, biomarkers, and therapeutic potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Animal models used to examine the role of the environment in the development of autoimmune disease: findings from an NIEHS Expert Panel Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Criteria for environmentally associated autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

IL-2: a two-faced master regulator of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Immune tolerance: what is unique about the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Autoimmunity in hepatitis C virus carriers: involvement of ferritin and prolactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

IL-6 contributes to an immune tolerance checkpoint in post germinal center B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Interleukin-17-producing T helper cells in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Biologics - beyond the joints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Systemic vascular diseases in the antiphospholipid syndrome. What is the best diagnostic choice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Autoimmunity and recurrent pregnancy losses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Predictors of pregnancy outcome in antiphospholipid syndrome: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Antiphospholipid antibody-mediated reproductive failure in antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Catastrophic antiphospholipid syndrome: updated diagnostic algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Catastrophic antiphospholipid syndrome associated with methicillin-resistant Staphylococcus aureus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Pregnancy outcomes in Japanese patients with SLE: retrospective review of 55 pregnancies at a university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Anti-endothelial antibodies interfere in apoptotic cell clearance and promote thrombosis in patients with antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Usefulness of cardiovascular biomarkers and cardiac imaging in systemic rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

From endothelial dysfunction to atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Geoepidemiology of COPD and idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Geoepidemiology of autoimmune liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Defining and analyzing geoepidemiology and human autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Geo-epidemiology and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Effects of tobacco smoke on immunity, inflammation and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Peptidylarginine deiminase 4 and citrullination in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8335-X

Interstitial lung disease in systemic sclerosis

21 January 2018

1 reference

12 December 2020

Managing lupus patients during pregnancy.

1 reference

12 December 2020

The role of chemokines in the recruitment of lymphocytes to the liver

1 reference

12 December 2020

Rituximab treatment of systemic lupus erythematosus in controlled trials and in clinical practice: Two sides of the same coin

1 reference

12 December 2020

The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis

1 reference

12 December 2020

Depletion of B cells in murine lupus: efficacy and resistance

1 reference

12 December 2020

De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process

1 reference

12 December 2020

The heart in rheumatoid arthritis

1 reference

12 December 2020

Contemporary challenges in human innate immunodeficiency syndromes

1 reference

12 December 2020

Pro-inflammatory role of Anti-Ro/SSA autoantibodies through the activation of Furin–TACE–amphiregulin axis

1 reference

12 December 2020

The revolution of epigenetics in the field of autoimmunity

1 reference

12 December 2020

Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma

1 reference

12 December 2020

Therapeutic update in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Cancer genomics: from discovery science to personalized medicine

1 reference

12 December 2020

High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein

1 reference

12 December 2020

Pulmonary dysfunction in systemic lupus erythematosus and anti-phospholipid syndrome patients

1 reference

12 December 2020

10.1007/S12016-012-8335-X

Identifiers

DOI

1 reference

PubMed ID

23054981

Dimensions Publication ID

27 August 2017

0 references

1 reference

PubMed ID

23054981